INVION
Invion has been appointed exclusive distributor and licensee in Australia and New Zealand of the PhotosoftTM technology by licensor The Cho Group, which is based in Hong Kong. The Cho Group has funded and successfully commercialised a number of unique, advanced technologies. Invion has an agreement with The Cho Group to conduct the clinical development of the PhotosoftTM technology globally. The Cho Group provides non-dilutive funding for the research into and clinical trials of PhotosoftTM via an R&D services agreement with Invion. The provision of non-dilutive funding is part of a global development strategy for PhotosoftTM.
INVION
Industry:
Biotechnology Product Research
Address:
East Kew, Victoria, Australia
Country:
Australia
Website Url:
http://www.inviongroup.com
Status:
Active
Contact:
+61 3 9081 6005
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Euro Google Maps Typekit MailChimp WordPress 5.5
Current Employees Featured
Official Site Inspections
http://www.inviongroup.com
- Host name: 23.185.0.2
- IP address: 23.185.0.2
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Invion"
About Invion โ Invion
Invion is a clinical-stage life-science company that is leading the global research and development of the Photosoft technology for the treatment of a range of cancers, atherosclerosis and โฆSee details»
Invion - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +61 3 9081 6005 Invion has been appointed exclusive distributor and licensee in Australia and New Zealand of the PhotosoftTM โฆSee details»
Board and Management Profiles โ Invion - inviongroup.com
He also currently sits on Stanford Medicineโs Center for Asian Health Research and Education (CARE) Advisory Board where he helps shape and advance CAREโs mission of enhancing the โฆSee details»
Invion investor hub | ASX:IVX
Welcome to Invion's (ASX:IVX) investor hub. View and interact with market data, announcements, annual reports, and investor presentationsSee details»
Invion Company Profile - Office Locations, Competitors, Revenue โฆ
Oct 4, 2024 Invion has 3 employees across 2 locations and $3.69 m in annual revenue in FY 2024. See insights on Invion including office locations, competitors, revenue, financials, โฆSee details»
ASX:IVX - Invion's Chair and CEO appointed to โฆ
Invion's Executive Chair, Thian Chew, has been appointed to the Advisory Board of the Stanford University School of Medicine's Center for Asian Health Research and Education (CARE). The appointment will present opportunities โฆSee details»
Invion - Overview, News & Similar companies | ZoomInfo.com
Oct 23, 2023 Invion contact info: Phone number: (302) 353-1190 Website: www.inviongroup.com What does Invion do? Invion is a clinical-stage life-sciences company โฆSee details»
Welcome to the Invion investor hub!
We welcome our shareholders and prospective shareholders to join the ASX:IVX investor hub and engage with the community.See details»
Corporate Governance โ Invion
Jun 30, 2023 Address : 100 Albert Road South Melbourne, VIC 3205 Phone : +61 3 9692 7222 Email : [email protected]See details»
Invion Company Profile | Management and Employees List
[email protected]: Invion Top Competitors. Company Employees Revenue Top technologies; Hua Medicine. n/a: $970 K: InteKrin Therapeutics Inc. n/a: $5.3 M: โฆSee details»
Invion Limited (ASX: IVX) Company Profile & Overview - Stock โฆ
Dec 6, 2024 Company profile for Invion Limited (ASX: IVX) with a description, list of executives, contact details and other key facts.See details»
Company Pipeline โ Invion
Address : 100 Albert Road South Melbourne, VIC 3205 Phone : +61 3 9692 7222 Email : [email protected]See details»
ASX:IVX - Frequently Asked Questions (FAQs)
Invion has received a number of enquirers from shareholders and we believe several of these questions will be of interest to all investors. In an effort to promote investor engagement and a โฆSee details»
Invion Ltd Company Summary & News ASX:IVX - abnnewswire.net
Sep 18, 2024 Invion Ltd (ASX:IVX) (OTCMKTS:IVIXF) (FRA:7C8) is a life-science company that is leading the global research and development of the Photosoft technology for the treatment โฆSee details»
Teams Profile โ Invion
Director Business Development, Starpharma. Program Manager, AusBiotech. Regulatory Affairs, Bayer CropScience. MBA Melb Business School, B. Applied Science RMITSee details»
ASX:IVX - Invion CEO, Thian Chew, outlines Invion's updated โฆ
Invion CEO, Thian Chew, outlines Invion's updated human clinical trial program in our latest Corporate Presentation.See details»
Discovery and Development Experts โ Invion - inviongroup.com
Seb has extensive career experience in the development of fine chemical products and in drug discovery. He was previously Project Leader of Pharmaceutical Chemicals Research at โฆSee details»
Invion investor hub - investors.inviongroup.com
View share price, top shareholders, your shareholding, and interact with announcements for Invion.See details»
ASX:IVX - Latest research update on Invion from Pitt Street
Pitt Street Research analysts Stuart Roberts and Nick Sundich just published an update on Invion as the Company advances its clinical programs in 2024. Click on the link below to read the โฆSee details»